Cyclerion Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCN and other ETFs, options, and stocks.About CYCN
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate.
CEORegina Graul
CEORegina Graul
Employees1
Employees1
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees1
Employees1
CYCN Key Statistics
Market cap9.87M
Market cap9.87M
Price-Earnings ratio-2.64
Price-Earnings ratio-2.64
Dividend yield—
Dividend yield—
Average volume14.52K
Average volume14.52K
High today$3.30
High today$3.30
Low today$3.05
Low today$3.05
Open price$3.05
Open price$3.05
Volume18.11K
Volume18.11K
52 Week high$9.47
52 Week high$9.47
52 Week low$1.27
52 Week low$1.27
People also own
Based on the portfolios of people who own CYCN. This list is generated using Robinhood data, and it’s not a recommendation.